All In Biotech

Investigational drug · Phase 3

Dexpramipexole Dihydrochloride

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Chronic Obstructive Pulmonary Disease, Eosinophilic Asthma, Asthma; Eosinophilic.

Phase 3

Last checked: Nov 19, 2026Latest source record: Sep 5, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

15

Any phase or sponsor naming "Dexpramipexole Dihydrochloride"

First trial start

2023

Jan 30, 2023

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Dexpramipexole Dihydrochloride", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Chronic Obstructive Pulmonary Disease
  • Eosinophilic Asthma
  • Asthma; Eosinophilic
  • Asthma Attack

Approved drugs for the same conditions: Asthma · COPD · Respiratory

Largest trials

Live from ClinicalTrials.gov: studies naming "Dexpramipexole Dihydrochloride" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Chronic Obstructive Pulmonary Disease

  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • ItepekimabREGN3500, SAR440340Phase 39 trials

    Sanofi · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Bronchiectasis

  • LunsekimigSAR443765Phase 39 trials

    Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • CM310Phase 35 trials

    Keymed Biosciences Co.Ltd · Atopic Dermatitis, Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease

  • TQC2731Phase 35 trials

    Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

  • VerducatibBI 1291583Phase 34 trials

    Boehringer Ingelheim · Bronchiectasis, Chronic Obstructive Pulmonary Disease

  • AstegolimabPhase 33 trials

    Roche (Genentech) · Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD)

  • CM326Phase 33 trials

    CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Moderate to Severe Asthma

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.